Showing results (461-470 of 566) with videos related to
Sort By:
Pageof 57
Blood|December 3, 1998
Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytesJ Chandra, I Niemer, J Gilbreath, et al.Cancer Genetics and Cytogenetics|October 1, 1994
High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvementA Younes, D Jendiroba, H Engel, et al.Leukemia|May 22, 2009
Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cellsB Z Carter, D H Mak, R Woessner, et al.British Journal of Cancer|December 9, 2010
Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphomaL Jin, Y Tabe, S Kimura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969J Gaynor, D Chapman, C Little, et al.Transplantation|January 28, 1999
Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparationsL Garderet, V Snell, D Przepiorka, et al.Leukemia|August 1, 2008
HOX expression patterns identify a common signature for favorable AMLM Andreeff, V Ruvolo, S Gadgil, et al.Leukemia|November 25, 2003
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemiasS Zhao, M Konopleva, M Cabreira-Hansen, et al.Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.Current Pharmaceutical Design|August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effectsM Milella, C M Precupanu, C Gregorj, et al.Pageof 57